Preliminary results of G>GVIELC:: A phase III trial of gemcitabine associated to vindesine or gemcitabine alone in elderly or poor performance patients with advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Santo, A.
Genestreti, G.
Azzoni, P.
Palmeri, S.
Caffo, O.
Cipriani, A.
Binato, E.
Cartei, G.
Portalone, L.
Sava, T.
Molino, A. M.
Cetto, G. L.
机构：
[1] Univ Verona, Verona Hosp, Dept Oncol, I-37100 Verona, Italy
[2] GIVOP, Verona, Italy
[3] Palermo Hosp, Oncol Unit, Palermo, Italy
[4] Trento Hosp, Oncol Unit, Trento, Italy
[5] Verona Hosp, Pneumol Unit, Verona, Italy
[6] Padova Hosp, Dept Oncol, Padua, Italy
[7] Forlanini Rome Hosp, Oncopneumol Unit, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：XI20 / XI20
页数：1
相关论文
共 50 条
  • [31] A phase II trial of thalidomide (T), irinotecan (I) and gemcitabine (G) in chemonaive patients (pts) with advanced non-small cell lung cancer (NSCLC).
    Flora, DB
    Kleykamp, B
    Knapp, M
    Shukla, R
    Jazieh, AR
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 680S - 680S
  • [32] A phase II trial of pemetrexed (P), gemcitabine (G), and bevacizumab (BV) in untreated patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Wozniak, Antoinette J.
    Kalemkerian, Gregory P.
    Gadgeel, Shirish M.
    Schneider, Bryan J.
    Valdivieso, Manuel
    Smith, Daryn
    Hackstock, Deborah M.
    Chen Wei
    Heilbrun, Lance K.
    Ruckdeschel, John D.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S454 - S454
  • [33] Biweekly carboplatin and gemcitabine for untreated advanced non-small cell lung cancer (NSCLC). A multicenter phase II trial
    Domine, M
    Gomez, RG
    Firvida, J
    Delgado, J
    Estevez, L
    Docampo, LI
    Leon, A
    Pachon, V
    Casado, V
    Lobo, F
    LUNG CANCER, 2005, 49 : S242 - S242
  • [34] Results of a phase III trial of erlotinib (OSI-774) combined with cisplatin and gemcitabine (GC) chemotherapy in advanced non-small cell lung cancer (NSCLC)
    Gatzemeier, U
    Pluzanska, A
    Szczesna, A
    Kaukel, E
    Roubec, J
    Brennscheidt, U
    De Rosa, F
    Mueller, B
    Von Pawel, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 619S - 619S
  • [35] A phase II trial of induction therapy with gemcitabine and carboplatin followed by concurrent gemcitabine and radiotherapy in locally advanced non-small cell lung cancer (NSCLC)
    Thongprasert, S
    Sukthomya, V
    Charoentum, C
    Pojchamarnwiputh, S
    Saengsawang, P
    LUNG CANCER, 2005, 49 : S393 - S393
  • [36] Vinorelbine/gemcitabine in advanced non-small-cell lung cancer (NSCLC): A phase I trial
    Pirker, R
    Krajnik, G
    MohnStaudner, A
    Marhold, F
    Malayeri, R
    Zochbauer, S
    Kummer, F
    Greil, R
    Huber, H
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1139 - 1139
  • [37] Gemcitabine monotherapy in the elderly patient with advanced non-small cell lung cancer
    Antonuzzo, A
    Galli, L
    Ricci, S
    Tibaldi, C
    Petruzzelli, S
    Tavanti, L
    Fioretto, ML
    Algeri, R
    Andrei, A
    Conte, PF
    ANNALS OF ONCOLOGY, 1998, 9 : 89 - 89
  • [38] Poor performance status (PS) patients with non-small cell lung cancer (NSCLC), biweekly carboplatin/gemcitabine regimen
    Lazaro, Martin
    ANNALS OF ONCOLOGY, 2006, 17 : 226 - 226
  • [39] A new biweekly schedule of carboplatin and gemcitabine: Phase I feasibility trial in patients with advanced non-small cell lung cancer (NSCLC).
    Mancuso, A
    Migliorino, MR
    Martelli, O
    Belli, R
    Di Molfetta, M
    De Petris, L
    Di Salvia, R
    De Marinis, F
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 677S - 677S
  • [40] Preliminary report an gemcitabine (G) - Ifosfamide (I) - Cisplatin (P) phase I/II trial in patients with advanced non small cell lung cancer (NSCLC)
    Bourgeois, H
    Lemerre, D
    Chicoyneau, V
    Paitry, T
    Chleze, S
    Fruge, F
    Boita, F
    Meurice, JC
    Daban, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S262 - S262
12345